首页 正文

[New development for targeted therapy of non-alcoholic fatty liver disease with thyroid hormone receptor beta]

{{output}}
Non-alcoholic fatty liver disease has now become a common hepatic metabolic disease, but there is no universally approved therapeutic drug on the market, so there is an urgent need to explore relevant therapeutic drugs. Several studies have shown that the thyr... ...